We are international
• health professionals TEXT SIZE   

Dr. Liebisch - Prognostic Impact of Chromosomal Abnormalities in Elderly Patients with Multiple Myeloma Treated with High-Dose Melphalan (MEL140) and Autologous Stem Cell Transplantation
Peter Liebisch, MD
University Hospital of Ulm
Ulm, Germany

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles